Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction.

Combination medical therapy including neurohormonal inhibitors and newer drugs, especially ARNI and SGLT2i, confers the maximum benefit with regard to HFrEF prognosis.